Cancer Communications | Home page

Cancer Communications | Home page

Cancer Communications

Affiliated with

• 
• 
• Cancer Communications is affiliated with Chinese Anti-Cancer Association and US Chinese Anti-Cancer Association.

Articles

• Recent
• Most accessed
• Collections

1. Content Type:Editorial

     |  3 August 2018

   Tumor vasculature: a sally port for inhibiting cancer cell spreading

   Authors:Chao-Nan Qian and Francesco Pezzella
2. Content Type:Original Article

     |  28 July 2018

   First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience

   Authors:Xiangyang Yu, Xuewen Zhang, Zichen Zhang, Yongbin Lin, Yingsheng Wen, Yongqiang Chen, Weidong Wang and Lanjun Zhang
3. Content Type:Original Article

     |  27 July 2018

   Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways

   Authors:Yanjun Huang, Sichun Zhou, Caimei He, Jun Deng, Ting Tao, Qiongli Su, Kwame Oteng Darko, Mei Peng and Xiaoping Yang
4. Content Type:Original Article

     |  25 July 2018

   Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining

   Authors:Minjie Zhang, Liu Wang, Ke An, Jun Cai, Guochao Li, Caiyun Yang, Huixian Liu, Fengxia Du, Xiao Han, Zilong Zhang, Zitong Zhao, Duanqing Pei, Yuan Long, Xin Xie, Qi Zhou and Yingli Sun
5. Content Type:Original Article

     |  17 July 2018

   Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients

   Authors:Ming Zhan, Rui-meng Yang, Hui Wang, Min He, Wei Chen, Sun-wang Xu, Lin-hua Yang, Qiang Liu, Man-mei Long and Jian Wang

Most recent articles RSS

View all articles